Parvovirus 4 in Individuals with Severe Hemophilia A and Matched Control Group

Background: Hemophilia is a well-known bleeding disorder with worldwide distribution. Replacement therapy, using plasma-derived or recombinant coagulation factors, comprises a gold standard regimen for the treatment. Regardless of the advancements made in viral inactivation methods in the production...

Descripción completa

Detalles Bibliográficos
Autores principales: Asiyabi, Sanaz, Marashi, Seyed Mahdi, Vahabpour, Rouhollah, Nejati, Ahmad, Azizi-Saraji, Alireza, Mustafa, Aliyeh Sadat, Baghernejad, Asgar, Shoja, Zabiholla, Mansouritorghabeh, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748245/
https://www.ncbi.nlm.nih.gov/pubmed/35083000
http://dx.doi.org/10.18502/ijhoscr.v15i3.6849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748245/
https://www.ncbi.nlm.nih.gov/pubmed/35083000
http://dx.doi.org/10.18502/ijhoscr.v15i3.6849

Ejemplares similares